Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 08:25 am Sale | 2025-09-30 | 13G | Zura Bio Limited ZURA | Deep Track Capital LP | 259,014 0.400% | -4,357,500 (-94.39%) | Filing History |
| 2025-11-14 08:24 am Sale | 2025-09-30 | 13G | Tectonic Therapeutic, Inc. TECX | Deep Track Capital LP | 0 0.000% | -1,401,938 (Position Closed) | Filing History |
| 2025-11-14 08:23 am Purchase | 2025-09-30 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Deep Track Capital LP | 3,000,000 7.110% | 647,040 (+27.50%) | Filing History |
| 2025-11-14 08:23 am Sale | 2025-09-30 | 13G | Protagonist Therapeutics, Inc. PTGX | Deep Track Capital LP | 1,715,691 2.760% | -1,534,309 (-47.21%) | Filing History |
| 2025-11-14 08:22 am Sale | 2025-09-30 | 13G | Pliant Therapeutics, Inc. PLRX | Deep Track Capital LP | 0 0.000% | -3,947,807 (Position Closed) | Filing History |
| 2025-11-14 08:20 am Sale | 2025-09-30 | 13G | Ocular Therapeutix, Inc. OCUL | Deep Track Capital LP | 13,095,855 6.180% | -2,362,283 (-15.28%) | Filing History |
| 2025-11-14 08:19 am Sale | 2025-09-30 | 13G | Mind Medicine (MindMed) Inc. MNMD | Deep Track Capital LP | 5,500,000 6.870% | -1,000,000 (-15.38%) | Filing History |
| 2025-11-14 08:18 am Sale | 2025-09-30 | 13G | Jade Biosciences, Inc. JBIO | Deep Track Capital LP | 2,279,892 6.990% | -504,756 (-18.13%) | Filing History |
| 2025-11-14 08:17 am Sale | 2025-09-30 | 13G | Invivyd, Inc. IVVD | Deep Track Capital LP | 0 0.000% | -9,722,254 (Position Closed) | Filing History |
| 2025-11-14 08:15 am Sale | 2025-09-30 | 13G | Inovio Pharmaceuticals, Inc. INO | Deep Track Capital LP | 1,314,796 2.410% | -1,279,026 (-49.31%) | Filing History |
| 2025-11-14 08:15 am Sale | 2025-09-30 | 13G | Structure Therapeutics Inc. GPCR | Deep Track Capital LP | 12,647,433 7.320% | -2,754,318 (-17.88%) | Filing History |
| 2025-11-14 08:13 am Sale | 2025-09-30 | 13G | 89bio, Inc. ETNB | Deep Track Capital LP | 9,356,171 6.310% | -4,460,162 (-32.28%) | Filing History |
| 2025-11-14 08:12 am Sale | 2025-09-30 | 13G | enGene Holdings Inc. ENGN | Deep Track Capital LP | 2,239,353 4.370% | -2,318,222 (-50.87%) | Filing History |
| 2025-11-14 08:09 am Sale | 2025-09-30 | 13G | Dianthus Therapeutics, Inc. DNTH | Deep Track Capital LP | 0 0.000% | -2,357,702 (Position Closed) | Filing History |
| 2025-11-14 08:09 am Sale | 2025-09-30 | 13G | Avalo Therapeutics, Inc. AVTX | Deep Track Capital LP | 0 0.000% | -114,775 (Position Closed) | Filing History |
| 2025-11-14 08:08 am Sale | 2025-09-30 | 13G | Autolus Therapeutics plc AUTL | Deep Track Capital LP | 2,568,613 0.970% | -12,703,559 (-83.18%) | Filing History |
| 2025-11-12 4:02 pm Purchase | 2025-11-05 | 13G | MoonLake Immunotherapeutics MLTX | Deep Track Capital LP | 4,610,071 6.460% | 4,610,071 (New Position) | Filing History |
| 2025-11-04 4:06 pm Purchase | 2025-10-28 | 13G | Cybin Inc. CYBN | Deep Track Capital LP | 3,072,250 6.090% | 2,072,250 (+207.22%) | Filing History |
| 2025-10-29 4:13 pm Purchase | 2025-09-30 | 13G | Cybin Inc. CYBN | Deep Track Capital LP | 1,000,000 3.970% | 1,000,000 (New Position) | Filing History |
| 2025-10-09 4:52 pm Purchase | 2025-10-02 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Deep Track Capital LP | 1,484,513 5.330% | 1,484,513 (New Position) | Filing History |